Floatz logo

azd6244

Stage IV Pancreatic Cancer

National Cancer Institute (NCI)Phase 2Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Stage IV Pancreatic Cancer cohort.

Asset / SponsorPhaseRating
Veliparib
National Cancer Institute (NCI)
Phase 2BB
Cediranib
M.D. Anderson Cancer Center
Phase 3BB
Sorafenib
HonorHealth Research Institute
Phase 2BB
PREDNISONE TABLETS
OHSU Knight Cancer Institute
Phase 2BB
FILGRASTIM
General Oncology, Inc.
Phase 2BB

View all 20 →

Same molecule, other indications

azd6244 is also rated in:

Colon NeoplasmsDormant
BB
Indicative ·
67 / 100
View asset →
malignant pancreatic neoplasmDormant
BB
Indicative ·
67 / 100
View asset →
uveal melanomaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →